论文部分内容阅读
为了探讨思密达对婴幼儿急性腹泻的治疗效果，我们将年龄在３岁以下，粪便呈水样便或蛋花汤样便，病程在５天以内符合病毒性腹泻的４５例急性腹泻患儿，随机抽样２０例取新鲜便作快速轮状病毒抗原检测，轮状病毒感染率为７５％。将病例随机分为三组：２０例为思密达治疗组；１０例为乳酸菌素片对照组；１５例为思密达联合抗生素对照组。治疗后三组结果：思密达治疗组和思密达联合抗生素对照组的总有效率分别为９５％、９３．５％，与乳酸菌素片组对照有显著差异（Ｐ＜０．０５）。尤其在平均退热天数和止泻天数方面都显著优于乳酸菌素片组（Ｐ≤０．０１）。思密达组与思密达联合抗生素组比较疗效无差异。
In order to explore the effect of Smectite on acute diarrhea in infants and young children, we will age less than 3 years old, stool was water or egg soup-like stool, within the course of 5 days in line with viral diarrhea in 45 children with acute diarrhea , 20 cases of random sampling of fresh rotavirus antigen for detection, rotavirus infection rate was 75%. The cases were randomly divided into three groups: 20 cases of Smecta treatment group; 10 cases of lactobacillus tablets control group; 15 cases of Smecta combined antibiotics control group. The results of three groups after treatment showed that the total effective rate was 95% and 93.5% in the Smecta and Smecta combination groups, respectively, which was significantly different from that in the Lactobacillus group (P <0.05). Especially in the average number of days and the number of antipyretic days were significantly better than lactobacillus tablets group (P ≤ 0.01). There was no difference between the Smectite and Smecta combined antibiotics groups.